CD28 and cancer: To execute their effector functions, T-cells should undergo rapid metabolic reprogramming (28, 29), which mainly involves upregulation of aerobic glycolysis by CD28 co-stimulation, acting through PI3K and Akt pathways (30, 31), very much alike the Warburg effect in cancer cells (32).